Page 153 - FINAL PROGRAM

P-353 3D ultrasound assessment of effect of controlled ovarian stimulation on endometrioma volume
A. Seyhan (Turkey)
P-354 Endometrial expression of progesterone receptors but not avb3 integrins is signi cantly decreased in women with unexplained infertility and poor ovarian reserve
S. Petousis (Greece)
P-355 Effects of low doses of mifepristone on the human embryo implantation process in a three-dimensional human endometrial in vitro co-culture system
C. von Grothusen (Sweden)
P-356 In vitro evaluation of therapeutic effects of red ginseng and identi cation of associated miRNAs in endometriosis
M.K. Kim (Korea, South)
P-357 Differential pro le of transcripts detected by RNA-Seq in eutopic endometrium of infertile women with endometriosis and fertile controls during the implantation window
R.A. Ferriani (Brazil)
P-358 Is luteal phase support successfully performed using 25 mg/day of subcutaneous progesterone in controlled ovarian stimulation cycles with GnRH agonist triggering? E.E. Lara (Spain)
P-359 GSTM1 polymorphisms in endometriosis in Greek women
D. Mavrogianni (Greece)
P-360 Effect of endometrial injury on reproductive outcome in assisted reproduction: an observational study
N. Garg (United Kingdom)
P-361 Transvaginal ultrasonography accelerated video recording is a reliable method for the assessment of uterine peristalsis before embryo transfer.
A. Castillo (Spain)
P-362 Intralipid in women with recurrent implantation failure in IVF/ICSI cycles. A double blinded randomised controlled trial
I. Gamaleldin (United Kingdom)
FINAL PROGRAMME I HELSINKI, FINLAND – 3 TO 6 JULY 2016 149
POSTERS